Request A Call Back

Category

Glipizide Manufacturing Thailand, the United Kingdom and USA
Inquiry Submitted Successfully

Glipizide

  • Product Name : Glipizide
  • Grade : IP / BP / USP
  • Therapeutic Category : Antidiabetic
  • CAS No : 29094-61-9
  • COA : Available
  • MSDS : Available

Description

Glipizide is an ATP-dependent K+ channels blocker in pancreatic β cells and brain GABA containing neurons resulting in insulin release.

Glipizide is an oral rapid- and short-acting anti-diabetic medication from the sulfonylurea class. It is classified as a second-generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.

 

Specification:

 

Tests

Specifications

Results

Appearance

White or almost white crystalline powder

White crystalline powder

Identification

IR: The IR absorption spectrum of sample corresponds to that of reference one

Complies

Loss on drying

Not more than 0.5%

0.1%

Residue on ignition

Not more than 0.2%

0.03%

Related substances

Impurity A

Impurity X3

Unspecified impurity

Total impurities

 

Not more than 0.3%

Not more than 0.15%

Not more than 0.10%

Not more than 0.5%

 

0.10%

0.08%

0.04%

0.26%

Impurity B

Not more than 0.01%

N.D

Assay

98.0%~102.0%

( Calculated on dried basis)

99.4%

Conclusion

Complies with BP

 

 Packaging details:

 

Packaging details:

25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.

Storage:

Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat

Shelf Life:

5 years if sealed and store away from direct sun light.

×